McNeil Consumer & Specialty Pharmaceuticals launches $30M campaign

Share this article:
Johnson & Johnson's McNeil Consumer & Specialty Pharmaceuticals launched a $30 million campaign for chewable Tylenol, targeting a younger-than-usual audience: 30- and 40-somethings with kids. The TV, print and poster ads, created by Deutsch, aim to capture the 30% of households where families fail to take headache remedies for reasons of inconvenience, according to Advertising Age.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.